A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma

Clinical Cancer Research

Volumn 13, Issue 10, 2007, Pages 2905-2915

  Vachani, Anil ^a   Nebozhyn, Michael ^b   Singhal, Sunil ^a   Alila, Linda ^b   Wakeam, Elliot ^a   Muschel, Ruth ^g   Powell, Charles A ^c   Gaffney, Patrick ^e   Singh, Bhuvanesh ^d   Brose, Marcia S ^a   Litzky, Leslie A ^a   Kucharczuk, John ^a   Kaiser, Larry R ^a   Marron, J Stephen ^f   Showe, Michael K ^b   Albelda, Steven M ^a   Showe, Louise C ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE LIGAND 13; COLLAGEN TYPE 6 ALPHA 2; CYTOKERATIN 14; GROWTH ARREST SPECIFIC 1; INTERSTITIAL COLLAGENASE; KALLIKREIN 10; MYOSIN HEAVY POLYPEPTIDE 2; PROTEIN; SURFACTANT PULMONARY ASSOCIATED PROTEIN B; TROPOMYOSIN 3; TSPY LIKE 5; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG SQUAMOUS CELL CARCINOMA; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENES, NEOPLASM; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 34249807326     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-1670     Document Type: Article

References (41)

1. Ferlito A, Shaha AR, Silver CE, et al. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001;63:202-7.
2. Jones AS, Morar P, Phillips DE, et al. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995;75:1343-53.
3. Nishizuka S, Chen ST, Gwadry FG, et al. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res 2003;63:5243-50.
4. Giordano TJ, Shedden KA, Schwartz DR, et al. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 2001;159:1231-8.
5. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 2001;98:15149-54.
6. O'Donnell RK, Kupferman M, Wei SJ, et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005;24:1244-51.
7. Singhal S, Wiewrodt R, Malden LD, et al. Gene expression profiling of malignant mesothelioma. Clin Cancer Res 2003;9:3080-97.
8. Ginos MA, Page GP, Michalowicz BS, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004;64:55-63.
9. Borczuk AC, Gorenstein L, Walter KL, et al. Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol 2003;163:1949-60.
10. Borczuk AC, Shah L, Pearson GD, et al. Molecular signatures in biopsy specimens of lung cancer. Am J Respir Crit Care Med 2004;170:167-74.
11. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 2001;98:13790-5.
12. Talbot SG, Estilo C, Maghami E, et al. Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. Cancer Res 2005;65:3063-71.
13. Bolstad BM, Irizarry RA, Astrand M, et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-93.
14. Vapnik V, Chapelle O. Bounds on error expectation for support vector machines. Neural Comput 2000;12:2013-36.
15. Benito M, Parker J, Du Q, et al. Adjustment of systematic microarray data biases. Bioinformatics 2004;20:105-14.
16. Marron JS, Todd MJ. Distance weighted discrimination technical report no. 1339. Ithaca (NY): School of Operations Research and Industrial Engineering, Cornell University; 2002.
17. Raychaudhuri S. Penalized discriminant analysis. Trends Biochem Sci 2001;19:189-93.
18. Hastie T, Buja A, Tibshirani R. Penalized discriminant analysis. Ann Surg 1995;23:73-102.
19. Fisher RA. The statistical utilization of multiple measurements. Ann Eugen 1938;8:376-86.
20. Kari L, Loboda A, Nebozhyn M, et al. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 2003;197:1477-88.
21. Gordon GJ, Jensen RV, Hsiao LL, et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res 2002;62:4963-7.
22. Cahan WG, Shah JP, Castro EB. Benign solitary lung lesions in patients with cancer. Ann Surg 1978;187:241-4.
23. Ginsberg RJ, Rubinstein LV; Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995;60:615-22; discussion 22-3.
24. Rusch VW. Pulmonary metastasectomy. Current indications. Chest 1995;107:322-31S.
25. Liu D, Labow DM, Dang N, et al. Pulmonary metastasectomy for head and neck cancers. Ann Surg Oncol 1999;6:572-8.
26. Leong PP, Rezai B, Koch WM, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 1998;90:972-7.
27. Geurts TW, Nederlof PM, van den Brekel MW, et al. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res 2005;11:6608-14.
28. Belbin TJ, Singh B, Barber I, et al. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 2002;62:1184-90.
29. Ambroise C, McLachlan GJ. Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci U S A 2002;99:6562-6.
30. Emens LA, Jaffee EM. To live or not to live: that depends on GAGE? Cancer Biol Ther 2002;1:388-90.
31. Cilensek ZM, Yehiely F, Kular RK, et al. A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, Interferon-γ, Taxol and γ-irradiation. Cancer Biol Ther 2002;1:380-7.
32. Duan Z, Duan Y, Lamendola DE, et al. Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin Cancer Res 2003;9:2778-85.
33. Melloni G, Ferreri AJ, Russo V, et al. Prognostic significance of cancer-testis gene expression in resected non-small cell lung cancer patients. Oncol Rep 2004;12:145-51.
34. Cheung IY, Chi SN, Cheung NK. Prognostic significance of GAGE detection in bone marrows on survival of patients with metastatic neuroblastoma. Med Pediatr Oncol 2000;35:632-4.
35. Zambon A, Mandruzzato S, Parenti A, et al. MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia. Cancer 2001;91:1882-8.
36. Barak V, Goike H, Panaretakis KW, et al. Clinical utility of cytokeratins as tumor markers. Clin Biochem 2004;37:529-40.
37. Bhowmick NA, Moses HL. Tumor-stroma interactions. Curr Opin Genet Dev 2005;15:97-101.
38. Sherman-Baust CA, Weeraratna AT, Rangel LB, et al. Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer Cell 2003;3:377-86.
39. Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000;6:4823-30.
40. Kurahara S, Shinohara M, Ikebe T, et al. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999;21:627-38.
41. Ramaswamy S. Translating cancer genomics into clinical oncology. N Engl J Med 2004;350:1814-6.